Cargando…

Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury

BACKGROUND: Matrix metalloproteinases (MMPs) are a family of extracellular endopeptidases that degrade the extracellular matrix and other extracellular proteins. Studies in experimental animals demonstrate that MMPs play a number of roles in the detrimental as well as in the beneficial events after...

Descripción completa

Detalles Bibliográficos
Autores principales: Buss, Armin, Pech, Katrin, Kakulas, Byron A, Martin, Didier, Schoenen, Jean, Noth, Johannes, Brook, Gary A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914362/
https://www.ncbi.nlm.nih.gov/pubmed/17594482
http://dx.doi.org/10.1186/1471-2377-7-17
_version_ 1782134132997881856
author Buss, Armin
Pech, Katrin
Kakulas, Byron A
Martin, Didier
Schoenen, Jean
Noth, Johannes
Brook, Gary A
author_facet Buss, Armin
Pech, Katrin
Kakulas, Byron A
Martin, Didier
Schoenen, Jean
Noth, Johannes
Brook, Gary A
author_sort Buss, Armin
collection PubMed
description BACKGROUND: Matrix metalloproteinases (MMPs) are a family of extracellular endopeptidases that degrade the extracellular matrix and other extracellular proteins. Studies in experimental animals demonstrate that MMPs play a number of roles in the detrimental as well as in the beneficial events after spinal cord injury (SCI). In the present correlative investigation, the expression pattern of several MMPs and their inhibitors has been investigated in the human spinal cord. METHODS: An immunohistochemical investigation in post mortem samples of control and lesioned human spinal cords was performed. All patients with traumatic SCI had been clinically diagnosed as having "complete" injuries and presented lesions of the maceration type. RESULTS: In the unlesioned human spinal cord, MMP and TIMP immunoreactivity was scarce. After traumatic SCI, a lesion-induced bi-phasic pattern of raised MMP-1 levels could be found with an early up-regulation in macrophages within the lesion epicentre and a later induction in peri-lesional activated astrocytes. There was an early and brief induction of MMP-2 at the lesion core in macrophages. MMP-9 and -12 expression peaked at 24 days after injury and both molecules were mostly expressed in macrophages at the lesion epicentre. Whereas MMP-9 levels rose progressively from 1 week to 3 weeks, there was an isolated peak of MMP-12 expression at 24 days. The post-traumatic distribution of the MMP inhibitors TIMP-1, -2 and -3 was limited. Only occasional TIMP immuno-positive macrophages could be detected at short survival times. The only clear induction was detected for TIMP-3 at survival times of 8 months and 1 year in peri-lesional activated astrocytes. CONCLUSION: The involvement of MMP-1, -2, -9 and -12 has been demonstrated in the post-traumatic events after human SCI. With an expression pattern corresponding largely to prior experimental studies, they were mainly expressed during the first weeks after injury and were most likely involved in the destructive inflammatory events of protein breakdown and phagocytosis carried out by infiltrating neutrophils and macrophages, as well as being involved in enhanced permeability of the blood spinal cord barrier. Similar to animal investigations, the strong induction of MMPs was not accompanied by an expression of their inhibitors, allowing these proteins to exert their effects in the lesioned spinal cord.
format Text
id pubmed-1914362
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19143622007-07-13 Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury Buss, Armin Pech, Katrin Kakulas, Byron A Martin, Didier Schoenen, Jean Noth, Johannes Brook, Gary A BMC Neurol Research Article BACKGROUND: Matrix metalloproteinases (MMPs) are a family of extracellular endopeptidases that degrade the extracellular matrix and other extracellular proteins. Studies in experimental animals demonstrate that MMPs play a number of roles in the detrimental as well as in the beneficial events after spinal cord injury (SCI). In the present correlative investigation, the expression pattern of several MMPs and their inhibitors has been investigated in the human spinal cord. METHODS: An immunohistochemical investigation in post mortem samples of control and lesioned human spinal cords was performed. All patients with traumatic SCI had been clinically diagnosed as having "complete" injuries and presented lesions of the maceration type. RESULTS: In the unlesioned human spinal cord, MMP and TIMP immunoreactivity was scarce. After traumatic SCI, a lesion-induced bi-phasic pattern of raised MMP-1 levels could be found with an early up-regulation in macrophages within the lesion epicentre and a later induction in peri-lesional activated astrocytes. There was an early and brief induction of MMP-2 at the lesion core in macrophages. MMP-9 and -12 expression peaked at 24 days after injury and both molecules were mostly expressed in macrophages at the lesion epicentre. Whereas MMP-9 levels rose progressively from 1 week to 3 weeks, there was an isolated peak of MMP-12 expression at 24 days. The post-traumatic distribution of the MMP inhibitors TIMP-1, -2 and -3 was limited. Only occasional TIMP immuno-positive macrophages could be detected at short survival times. The only clear induction was detected for TIMP-3 at survival times of 8 months and 1 year in peri-lesional activated astrocytes. CONCLUSION: The involvement of MMP-1, -2, -9 and -12 has been demonstrated in the post-traumatic events after human SCI. With an expression pattern corresponding largely to prior experimental studies, they were mainly expressed during the first weeks after injury and were most likely involved in the destructive inflammatory events of protein breakdown and phagocytosis carried out by infiltrating neutrophils and macrophages, as well as being involved in enhanced permeability of the blood spinal cord barrier. Similar to animal investigations, the strong induction of MMPs was not accompanied by an expression of their inhibitors, allowing these proteins to exert their effects in the lesioned spinal cord. BioMed Central 2007-06-26 /pmc/articles/PMC1914362/ /pubmed/17594482 http://dx.doi.org/10.1186/1471-2377-7-17 Text en Copyright © 2007 Buss et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Buss, Armin
Pech, Katrin
Kakulas, Byron A
Martin, Didier
Schoenen, Jean
Noth, Johannes
Brook, Gary A
Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title_full Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title_fullStr Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title_full_unstemmed Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title_short Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
title_sort matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914362/
https://www.ncbi.nlm.nih.gov/pubmed/17594482
http://dx.doi.org/10.1186/1471-2377-7-17
work_keys_str_mv AT bussarmin matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT pechkatrin matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT kakulasbyrona matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT martindidier matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT schoenenjean matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT nothjohannes matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury
AT brookgarya matrixmetalloproteinasesandtheirinhibitorsinhumantraumaticspinalcordinjury